Literature DB >> 34178900

The 46, XX Ovotesticular Disorder of Sex Development With Xq27.1q27.2 Duplication Involving the SOX3 Gene: A Rare Case Report and Literature Review.

Jianlong Zhuang1, Chunnuan Chen2, Jia Li3, Yuying Jiang1, Junyu Wang1, Yuanbai Wang1, Shuhong Zeng1, Yiming Lin4, Yingjun Xie5,6.   

Abstract

Background: Very few reports are available on human XX ovotesticular disorder of sex development involving SOX3 gene duplication. Here we aim to present a rare case of SOX3 gene duplication in a person from the Chinese population who exhibits XX ovotesticular disorder of sex development. Case Presentation: A 7-year-old Chinese individual from Fujian province in Southeast China was recruited. The patient presented 46, XX karyotype, absence of sex-determining region Y, and was diagnosed with XX ovotesticular disorder of sex development. Furthermore, SNP array analysis demonstrated that the patient had a 2.2-Mb duplication in the Xq27.1q27.2 region (arr[hg19]Xq27.1q27.2:139,499,778-141,777,782) involving the SOX3 gene. Additionally, no SOX3 duplication was observed in the parents or the sibling, who displayed none of the clinical features.
Conclusion: We identified the first case of SOX3 duplication in a Chinese individual who exhibits ovotesticular disorder of sex development. Our study strengthens the link between the SOX3 duplication and XX ovotesticular disorder of sex development and indicates that SOX3 is the evolutionary antecedent of sex-determining region Y.
Copyright © 2021 Zhuang, Chen, Li, Jiang, Wang, Wang, Zeng, Lin and Xie.

Entities:  

Keywords:  SOX3 gene; Xq27.1q27.2 duplication; chromosomal microarray analysis; disorder of sex development; ovotestis

Year:  2021        PMID: 34178900      PMCID: PMC8225946          DOI: 10.3389/fped.2021.682846

Source DB:  PubMed          Journal:  Front Pediatr        ISSN: 2296-2360            Impact factor:   3.418


Introduction

Sex-determining region Y (SRY) is the key gene in 46, XY normal males. SRY initiates a complex genetic cascade, promoting the differentiation of the testis. However, the coexistence of ovarian and testicular tissues is present in some 46, XX individuals, which refers to as ovotesticular disorder of sex development (OT-DSD) (1, 2). Studies have shown that the occurrence of 46, XX OT-DSD is related to the dislocation recombination on the X and Y chromosomes during the meiosis of the paternal chromosome, which transfers the SRY gene from the Y chromosome to X (3), but only few patients with 46, XX OT-DSD have a detectable SRY gene; most of the subjects show an absence of the SRY gene (4, 5). However, the SRY gene is present in most of (~80%) 46, XX testicular DSD cases (6). Currently, it is believed that sex determination and differentiation are processes of orderly and coordinated expression of autosomal and sex chromosomes, but with the SRY gene, abnormalities in any process can lead to sex abnormalities. As we know, SRY up-regulates the expression of SRY-Box transcription factor 9 (SOX9) in bipotential gonads, leading to the differentiation of testicular cells and eventually testicular differentiation (7). Moreover, a study has shown that ectopic SOX9 expression induces the formation of mouse testis in XX gonads (8). Recently, several cases have been reported to carry SOX9 duplications (9–12), which have been proposed to be responsible for SOX9 expression during gonad development. SRY-Box transcription factor 3 (SOX3), located on the chromosome X (Xq27.1), is a member of the SRY-Box transcription factor family (13). Duplications involving the SOX3 gene have been reported to be associated with developmental delay, intellectual disability, growth hormone deficiency, infundibular hypoplasia and hypopituitarism, etc. (14, 15). Recently, XX sex reversal has been reported in transgenic mice with ectopic SOX3 expression and observed in 46, XX DSD patients with duplications of SOX3 or genomic rearrangements within the SOX3 regulatory region (16). Few reports are available on 46, XX SRY-negative males with SOX3 duplications, though a recent study conducted by Tasic et al. revealed a 46, XX male who presented congenital anomalies of kidneys and the urinary tract and had a duplication on chromosome Xq27 involving the SOX3 gene, indicating links between SOX3 gene dosage and kidney malformations and sex determination (17). Moreover, a study has shown a 46, XX SRY-negative individual with duplication of the SOX3 gene exhibiting XX OT-DSD (18). In the present study, we describe a 7-year-old OT-DSD case with Xq27.1q27.2 duplication involving the SOX3 gene, which was first identified in Chinese individuals and additionally strengthened the pathogenic role of SOX3 duplication in XX OT-DSD.

Case Presentation

The patient comes from Quanzhou City, Fujian province, in Southeast China. The child was delivered vaginally with a birth weight of 3.7 kg. There was no family history of DSD, and the parents denied any consanguinity. A physical examination showed the child presented ambiguous sex, coronal hypospadias, a penis or enlarged clitoris, and the presence of a scrotum but non-palpable gonads. Subsequent ultrasonography indicated that the patient might have the coexistence of testicular and ovarian tissues on the left side and testicular tissue on the right side. After clinical consultation, the family decided to raise the child as a male, and ovariectomy was performed at 10 months after birth, to remove the ovarian section from the left ovotesticular area. The subsequent histology analysis confirmed the presence of unilateral ovotestes tissues in the left side of the patient. At age 7, the child's height (130 cm) and weight (23 kg) were within the normal ranges. Hormonal laboratory tests showed low luteinizing hormone (<0.20 mIU/ml), follicle-stimulating hormone (1.21 mIU/ml) and testosterone (<0.10 ng/ml). Serum progesterone and prolactin were normal. Currently, human menopausal gonadotropin (menotropins for injection, AnHui BBCA Pharmaceutical Co., Ltd.) is injected for treatment with 150 U a day. Regular follow-up showed normal penile and testicular development, with normal morning erection. Chromosome G-banding analysis revealed a normal karyotype (46, XX) in the patient. The parental karyotypes were normal as well. Chromosomal microarray analysis demonstrated that the patient had a 2.2-Mb duplication in the Xq27.1q27.2 region (arr[hg19]Xq27.1q27.2:139,499,778-141,777,782) of the X chromosome (Figure 1). The duplication contains 12 Online Mendelian Inheritance in Man (OMIM) genes: CDR1, LDOC1, MAGEC1, MAGEC2, MAGEC3, SOX3, SPANXA1, SPANXA2, SPANXB1, SPANXB2, SPANXC, and SPANXD. SNP array analysis was also performed on parental and sibling blood samples. Chromosomal microarray results showed that none of the Y chromosome was observed, and further study indicated that no SRY gene was observed in the patient by polymerase chain reaction. Furthermore, no SOX3 duplication was observed in the parents or the sibling with normal phenotype.
Figure 1

The breakpoint of Xq27.1q27.2 duplication in our study. The upper panel shows the schematic representation of chromosome X. The red rectangle displays the genomic location of Xq27.1q27.2 on the chromosome X. The lower panel presents a magnified view of the Xq27.1q27.2 duplication (arr[hg19] chrX: 139,499,778- 141,777,782) involving the SOX3 gene.

The breakpoint of Xq27.1q27.2 duplication in our study. The upper panel shows the schematic representation of chromosome X. The red rectangle displays the genomic location of Xq27.1q27.2 on the chromosome X. The lower panel presents a magnified view of the Xq27.1q27.2 duplication (arr[hg19] chrX: 139,499,778- 141,777,782) involving the SOX3 gene.

Discussion and Conclusion

OT-DSD is the disease defined as presence of both male and female gonads. The SRY gene is present in few cases of 46, XX OT-DSD patients, which can explain testicular development (18). However, the SRY gene is absent in the most of 46, XX OT-DSD patients, and the mechanism underlying the testis development is not fully understood. SOX genes are considered key players in the regulation of nervous system development and embryogenesis; they encode transcription factors that act as key regulators in a variety of developmental processes, including specification, gastrulation, cellular differentiation, and neural induction (19). SOX9 is critical to the human testis differentiation, while it is still poorly understood whether SOX3 expression affects sex differentiation. A study showed knockout of SOX3 did not cause any defects of sex determination; however, affected testis differentiation and oocyte development were observed in SOX3-null mice (20). Moreover, another study showed that SOX3 mutations were absent in the subjects diagnosed with 46, XY gonadal dysgenesis and 46, XX sex reversal, indicating that SOX3 might not be involved in testis differentiation (21). Recent studies have shown that several human XX male sex reversal cases present rearrangements of the SOX3 locus, suggesting that a defect in the SOX3 gene might result in XX male sex reversal in mice and humans. Therefore, researchers believe that SRY may arise from SOX3 and the two genes have interchangeable functions in sex determination (16, 22). The study conducted by Sutton et al. (16) showed three patients with XX male sex reversal exhibiting rearrangements encompassing or in proximity of SOX3. Patient A had two microduplications, one of which covered the entire SOX3 gene; patient B carried a microdeletion located upstream of SOX3 in Xq27.1; patient C had a large duplication that encompassed the SOX3 gene and at least 18 additional genes, which might be responsible for the clinical phenotype (Table 1). Additionally, another study by Moalem et al. (22) showed de novo SOX3 gene duplication in XX male sex reversal with genital abnormalities. The patient exhibited a partial sex reversal with abnormal genitalia and had three copy number variants, the first of which was a 494-kb duplication in region Xq27.1, which encompassed the SOX3 gene. The phenotype might be associated with weak or slightly late ectopic expression of SOX3 in the early gonads. Subsequently, a study (18) identified the first 46, XX OT-DSD case who showed a SOX3 duplication, with absence of SRY, and presented hypospadias and bilateral cryptorchidism (Table 1).
Table 1

Literature review of the involvement of SOX3 duplications in disorders of sex development.

Wood et al., Family A Patient 1Wood et al., Family APatient 2Sutton et al., Patient ASutton et al.,Patient CMoalem et al., Patient 1Grinsponet al., PatientOur case
Disorders of sex developmentXX male reversal.XX male reversal.XX male reversal.XX male reversal.XX male reversal.OT-DSDOT-DSD
Age7 years2.5 years30 years1.5 years1 year2.5 years7 years
Growth and developmental issuesGH deficiency; Normal serum prolactin and cortisol. Psychomotor development.History of neonatal hypoglycemia; severe cortisol, TSH, GH, and gonadotrophin deficiency. He has normal psychomotor development but has been noted to be hyperactive.NormalDevelopmental and growth delay; microcephaly.NormalNormalNormal
Genitals and testisDetails not reported.Hypoplastic genitalia, with both testes palpable high in the inguinal canal and a micropenis.Details not reported.Right testicles appear smaller than left; Hypoplastic scrotum; testes are retractile and can be brought down.Penoscrotal hypospadias with a bifid scrotum; phallus was otherwise unremarkable with erectile tissue palpable; on ultrasound epididymis appearing grossly normal.The testicular tissue and ovarian tissue all exist.The ovotesticular tissue on the left side and the testicular tissue on the right side.
VulvaMaleMaleMaleMaleBilateral cryptorchidism.Hypospadias and bilateral cryptorchidism.Hypospadias and bilateral cryptorchidism.
SRYUnknownUnknownNegativeNegativeNegativeNegativeNegative
GenotypesTandem duplication 685.6 kb in length on the X chromosome that spanned the SOX3 gene.Tandem duplication 685.6 kb in length on the X-chromosome which spanned the SOX3 geneTwo microduplications were observed, the first of which spanned the entire SOX3 gene6 Mb duplication that encompasses SOX3 and at least 18 additional distally located genes.Three microduplications were observed, the first of which contains the SOX3 gene.502 kb duplication that encompasses SOX3 gene and its regulatory sequences.2.2 Mb duplication that encompasses SOX3 gene.
InheritanceMaternally derived.Maternally derivedUnknownUnknownDe novoDe novoDe novo
Literature review of the involvement of SOX3 duplications in disorders of sex development. In our study, we secondly identified a 46, XX OT-DSD case with SOX3 gene duplication, which was first found in Chinese individuals. The findings are in agreement with the previous studies, supporting the notion that duplication of SOX3 is responsible for partial testicular differentiation in the fetal XX gonads. In this study, apart from the SOX3 gene, 11 OMIM genes were also involved in this duplicated region. Previous studies indicated that the MAGE genes and SPANX genes are specifically expressed in tumors and testis (23–25), which needs further investigation as to the potential relationship between these genes and sex determination. In conclusion, our study firstly identified a patient carrying the Xq27.1q27.2 duplication involving the SOX3 gene in a 46, XX OT-DSD Chinese individual, which provides additional evidence that the duplication of SOX3 is pathological in the XX OT-DSD and further indicates that SOX3 may be the evolutionary antecedent of SRY. However, more work can be done on the expression of SOX9 or other genes that affect the gonadal differentiation pathway, such as WNT4 or RSPO1.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics Statement

The studies involving human participants were reviewed and approved by Ethics Committee of Quanzhou women's and children's hospital. We confirmed that all subjects who participated in this study signed written informed consent for publishing their own and their children's genetic data and relevant information.

Author Contributions

JZ and CC designed the study and wrote the article. JW, SZ, and YW performed the karyotype analysis and analyzed the data. YJ, JL, YL, and YX revised and polished the manuscript. All authors approved the final article.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  24 in total

1.  Mutation analysis of subjects with 46, XX sex reversal and 46, XY gonadal dysgenesis does not support the involvement of SOX3 in testis determination.

Authors:  H N Lim; G D Berkovitz; I A Hughes; J R Hawkins
Journal:  Hum Genet       Date:  2000-11-14       Impact factor: 4.132

2.  The human SPANX multigene family: genomic organization, alignment and expression in male germ cells and tumor cell lines.

Authors:  Albert J W Zendman; Jürgen Zschocke; Annemieke A van Kraats; Nicole J W de Wit; Maciej Kurpisz; Ulrich H Weidle; Dirk J Ruiter; Elisabeth H Weiss; Goos N P van Muijen
Journal:  Gene       Date:  2003-05-08       Impact factor: 3.688

3.  Sox3 is required for gonadal function, but not sex determination, in males and females.

Authors:  Jeffrey Weiss; Joshua J Meeks; Lisa Hurley; Gerald Raverot; Andrea Frassetto; J Larry Jameson
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

4.  A SOX9 duplication and familial 46,XX developmental testicular disorder.

Authors:  James J Cox; Lionel Willatt; Tessa Homfray; C Geoffrey Woods
Journal:  N Engl J Med       Date:  2011-01-06       Impact factor: 91.245

5.  Transcription factor SOX3 is involved in X-linked mental retardation with growth hormone deficiency.

Authors:  Frédéric Laumonnier; Nathalie Ronce; Ben C J Hamel; Paul Thomas; James Lespinasse; Martine Raynaud; Christine Paringaux; Hans Van Bokhoven; Vera Kalscheuer; Jean-Pierre Fryns; Jamel Chelly; Claude Moraine; Sylvain Briault
Journal:  Am J Hum Genet       Date:  2002-11-08       Impact factor: 11.025

6.  XX male sex reversal with genital abnormalities associated with a de novo SOX3 gene duplication.

Authors:  Sharon Moalem; Riyana Babul-Hirji; Dmitri J Stavropolous; Diane Wherrett; Darius J Bägli; Paul Thomas; David Chitayat
Journal:  Am J Med Genet A       Date:  2012-06-07       Impact factor: 2.802

Review 7.  True hermaphroditism: geographical distribution, clinical findings, chromosomes and gonadal histology.

Authors:  G Krob; A Braun; U Kuhnle
Journal:  Eur J Pediatr       Date:  1994-01       Impact factor: 3.183

8.  Identification of SOX3 as an XX male sex reversal gene in mice and humans.

Authors:  Edwina Sutton; James Hughes; Stefan White; Ryohei Sekido; Jacqueline Tan; Valerie Arboleda; Nicholas Rogers; Kevin Knower; Lynn Rowley; Helen Eyre; Karine Rizzoti; Dale McAninch; Joao Goncalves; Jennie Slee; Erin Turbitt; Damien Bruno; Henrik Bengtsson; Vincent Harley; Eric Vilain; Andrew Sinclair; Robin Lovell-Badge; Paul Thomas
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

9.  Over- and underdosage of SOX3 is associated with infundibular hypoplasia and hypopituitarism.

Authors:  Kathryn S Woods; Maria Cundall; James Turton; Karine Rizotti; Ameeta Mehta; Rodger Palmer; Jacqueline Wong; W K Chong; Mahmoud Al-Zyoud; Maryam El-Ali; Timo Otonkoski; Juan-Pedro Martinez-Barbera; Paul Q Thomas; Iain C Robinson; Robin Lovell-Badge; Karen J Woodward; Mehul T Dattani
Journal:  Am J Hum Genet       Date:  2005-03-30       Impact factor: 11.025

10.  Human sex reversal is caused by duplication or deletion of core enhancers upstream of SOX9.

Authors:  Brittany Croft; Thomas Ohnesorg; Jacqueline Hewitt; Josephine Bowles; Alexander Quinn; Jacqueline Tan; Vincent Corbin; Emanuele Pelosi; Jocelyn van den Bergen; Rajini Sreenivasan; Ingrid Knarston; Gorjana Robevska; Dung Chi Vu; John Hutson; Vincent Harley; Katie Ayers; Peter Koopman; Andrew Sinclair
Journal:  Nat Commun       Date:  2018-12-14       Impact factor: 14.919

View more
  1 in total

Review 1.  Duplication of SOX3 in an SRY-negative 46,XX male with prostatic utricle: case report and literature review.

Authors:  Jiansheng Wei; Changrong Liu; Minyan Zhang; Shen Liu; Junjie Fu; Peng Lin
Journal:  BMC Med Genomics       Date:  2022-09-05       Impact factor: 3.622

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.